Ameritas Investment Partners, Inc. - CRINETICS PHARMACEUTICALS IN ownership

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 86 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$192,626
+168.1%
6,477
+62.5%
0.01%
+166.7%
Q2 2023$71,846
+12.2%
3,9870.0%0.00%0.0%
Q1 2023$64,031
-19.3%
3,9870.0%0.00%0.0%
Q4 2022$79,341
+1.7%
3,9870.0%0.00%0.0%
Q3 2022$78,000
+5.4%
3,9870.0%0.00%0.0%
Q2 2022$74,000
-5.1%
3,987
+11.9%
0.00%0.0%
Q1 2022$78,000
-22.8%
3,5620.0%0.00%0.0%
Q4 2021$101,000
+68.3%
3,562
+24.5%
0.00%
+50.0%
Q3 2021$60,000
+11.1%
2,8600.0%0.00%0.0%
Q2 2021$54,000
+45.9%
2,860
+19.7%
0.00%
+100.0%
Q1 2021$37,000
+8.8%
2,3900.0%0.00%
-50.0%
Q4 2020$34,000
-8.1%
2,3900.0%0.00%0.0%
Q3 2020$37,000
-11.9%
2,3900.0%0.00%0.0%
Q2 2020$42,000
+200.0%
2,390
+151.1%
0.00%
+100.0%
Q1 2020$14,000
-41.7%
9520.0%0.00%0.0%
Q4 2019$24,000
+71.4%
9520.0%0.00%0.0%
Q3 2019$14,000
-41.7%
9520.0%0.00%0.0%
Q2 2019$24,000
+84.6%
952
+65.9%
0.00%0.0%
Q1 2019$13,000
-23.5%
5740.0%0.00%0.0%
Q4 2018$17,000
+6.2%
5740.0%0.00%0.0%
Q3 2018$16,0005740.00%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Saturn V Capital Management LP 623,819$11,336,5019.41%
Finepoint Capital LP 822,745$15,0564.87%
Bain Capital Life Sciences Investors, LLC 2,305,558$42,1924.72%
Opaleye Management Inc. 732,000$13,395,6004.66%
5AM Venture Management, LLC 862,286$15,779,8344.24%
SPHERA FUNDS MANAGEMENT LTD. 671,644$12,291,0852.64%
First Light Asset Management, LLC 1,329,313$24,326,4282.26%
BRAIDWELL LP 3,469,674$63,495,0342.13%
BVF INC/IL 2,736,613$50,080,0182.11%
Perceptive Advisors 4,039,276$73,918,7512.08%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders